These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867 [TBL] [Abstract][Full Text] [Related]
3. [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)]. Imai R Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1143-52. PubMed ID: 2273577 [TBL] [Abstract][Full Text] [Related]
4. [Increase in the activated (HLA-DR+) T-cells in the peripheral blood lymphocyte of patients with alopecia areata]. Imai R; Miura J; Numata K; Aikawa Y; Takamori K; Ogawa H Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):355-60. PubMed ID: 3261812 [No Abstract] [Full Text] [Related]
5. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Duvic M; Hordinsky MK; Fiedler VC; O'Brien WR; Young R; Reveille JD Arch Dermatol; 1991 Jan; 127(1):64-8. PubMed ID: 1670917 [TBL] [Abstract][Full Text] [Related]
6. [HLA antigens of patients with alopecia areata]. Averbakh EV; Pospelov LE Vestn Dermatol Venerol; 1986; (1):24-6. PubMed ID: 3457498 [No Abstract] [Full Text] [Related]
7. Decreased in vitro lymphocyte stimulation and reduced sensitivity to IL-2 in patients with alopecia areata. Orecchia G; Capelli E; Martinetti M; Cuccia Belvedere M; Rabbiosi G Arch Dermatol Res; 1988; 280 Suppl():S47-50. PubMed ID: 3261574 [TBL] [Abstract][Full Text] [Related]
9. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Sato-Kawamura M; Aiba S; Tagami H Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779 [TBL] [Abstract][Full Text] [Related]
10. [Alopecia areata--clinical and immunological characteristics]. Broniarczyk-Dyła G Przegl Dermatol; 1990; 77(5):363-6. PubMed ID: 2270299 [No Abstract] [Full Text] [Related]
11. [HLA antigens in alopecia areata]. Deng JH Zhonghua Yi Xue Za Zhi; 1989 Jan; 69(1):44-5. PubMed ID: 2758346 [No Abstract] [Full Text] [Related]
12. Investigation of the HLA-DRB1 locus in alopecia areata. Entz P; Blaumeiser B; Betz RC; Lambert J; Seymons K; Eigelshoven S; Hanneken S; Kruse R; Nürnberg P; Nagy M; Nöthen MM Eur J Dermatol; 2006; 16(4):363-7. PubMed ID: 16935791 [TBL] [Abstract][Full Text] [Related]
13. HLA class II alleles in patients with alopecia areata. Akar A; Orkunoglu E; Sengül A; Ozata M; Gür AR Eur J Dermatol; 2002; 12(3):236-9. PubMed ID: 11978563 [TBL] [Abstract][Full Text] [Related]
14. Increased HLA-DR+ T-lymphocyte population in peripheral blood of alopecia areata. Imai R; Miura J; Takamori K; Ogawa H Clin Exp Dermatol; 1991 May; 16(3):176-80. PubMed ID: 1934567 [TBL] [Abstract][Full Text] [Related]
16. Trial of intralesional interferon alfa in the treatment of alopecia areata. Magee KL; Hsu SM; Tucker SB Arch Dermatol; 1990 Jun; 126(6):760-2. PubMed ID: 2189361 [TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-DR in hair follicles in alopecia areata. Messenger AG; Bleehen SS; Slater DN; Rooney N Lancet; 1984 Aug; 2(8397):287-8. PubMed ID: 6146835 [No Abstract] [Full Text] [Related]
18. HLA class II antigen associations help to define two types of alopecia areata. Colombe BW; Price VH; Khoury EL; Garovoy MR; Lou CD J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):757-64. PubMed ID: 7593774 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466 [TBL] [Abstract][Full Text] [Related]